Zydus Life Science Gets CDSCO Panel Nod To Manufacture and Market Anti-cancer Drug Nelarabine Dr. Divya Colin21 Jun 2024 6:00 PM ISTNew Delhi: In a significant development, the drug major Zydus Life Science has got approval from the Subject Expert Committee (SEC) functional under...
CDSCO Panel Rejects Roche Products India local Phase III CT waiver proposal for Atezolizumab injection SC route Dr. Divya Colin18 Jun 2024 6:00 PM ISTNew Delhi: Recommending to conduct a phase III study in the Indian population to establish the safety and efficacy, the Subject Expert Committee (SEC)...
BDR Pharmaceuticals gets CDSCO panel nod to manufacture, market anticancer drug Abiraterone Acetate Oral Suspension Dr. Divya Colin8 Jun 2024 10:07 PM ISTNew Delhi: In a significant development, BDR Pharmaceuticals has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central...
Alkem Laboratories Gets CDSCO Panel Nod To Manufacture Market Relugolix Tablets 120mg Dr. Divya Colin13 May 2024 6:00 PM ISTNew Delhi: Alekm Laboratories has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Novartis Gets CDSCO Panel Nod to Study anti-cancer drug Ribociclib Dr. Divya Colin21 April 2024 5:30 PM ISTNew Delhi: The drug major Novartis has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Conduct Phase III clinical trial: CDSCO Panel Tells BDR Pharmaceutical on Anti-cancer Drug Abiraterone Acetate Dr. Divya Colin20 April 2024 5:45 PM ISTNew Delhi: Reviewing the justification for waiver of the Phase III clinical trial of the anti-cancer drug Abiraterone Acetate presented by BDR...
Dr.Reddy's Labs gets CDSCO Panel Nod To Manufacture, Market anti-cancer drug Lenalidomide 20mg additional strength Dr. Divya Colin19 April 2024 6:00 PM ISTNew Delhi: The drug major Dr Reddy's Labs has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Submit Current Safety Data of Indians: CDSCO Panel Tells Glenmark on anti-cancer drug ISB1442 Dr. Divya Colin26 March 2024 6:00 PM ISTNew Delhi: Reviewing the Phase I/II clinical study protocol of the anti-cancer drug ISB1442 presented by the drug major Glenmark, the Subject Expert...
CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal For Anti-cancer Drug Osimertinib Dr. Divya Colin25 March 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Pfizer Gets CDSCO Panel Nod To study anti-cancer drug Lorlatinib Dr. Divya Colin24 March 2024 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Merck Speciality gets CDSCO Panel Nod To study anti-cancer drug Avelumab Dr. Divya Colin22 March 2024 5:45 PM ISTNew Delhi: The drug major Merck Speciality has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
AstraZeneca Gets CDSCO Panel Nod to Study anticancer drug Volrustomig Dr. Divya Colin17 March 2024 6:00 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
